Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation
NCT ID: NCT02031549
Last Updated: 2015-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2014-01-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation
NCT02268123
Split Cohort Trial Comparing IVF Outcomes After the Use of Testicular vs. Ejaculated Sperm for ICSI
NCT03483298
Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?
NCT05837325
Sperm DNA Fragmentation Effects on Blastocyst Morphology Grading, Pregnancy Rate and Implantation Rate
NCT04144621
Study of Assisted Hatching of Cleavage Stage Embryos
NCT00120549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SpermComet Assay
All study subjects will have their surplus sperm analyzed for DNA fragmentation with the SpermComet assay.
SpermComet assay
Measurement of DNA fragmentation in samples of surplus sperm (diagnostic, not an intervention).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SpermComet assay
Measurement of DNA fragmentation in samples of surplus sperm (diagnostic, not an intervention).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surplus sperm available after oocyte insemination
* Consented
Exclusion Criteria
* Use of donated sperm or oocytes
* No minors may participate
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bruce Shapiro M.D.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruce Shapiro M.D.
Medical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruce Shapiro, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Fertility Center of Las Vegas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fertility Center of Las Vegas
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAIRB-13-0038
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.